Last10K.com

Sellas Life Sciences Group, Inc. (SLS) SEC Filing 8-K Material Event for the period ending Wednesday, March 6, 2019

Sellas Life Sciences Group, Inc.

HISTORY TOOLS
CIK: 1390478 Ticker: SLS

View differences made from one to another to evaluate Sellas Life Sciences Group, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Sellas Life Sciences Group, Inc..

Continue

Assess how Sellas Life Sciences Group, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Sellas Life Sciences Group, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Sellas Life Sciences Group, Inc. provided additional information to their SEC Filing as exhibits

Exhibit 4.1: Instruments Defining The Rights Of Security Holders, Including Indentures
Exhibit 10.1: Material Contract
Ticker: SLS
CIK: 1390478
Form Type: 8-K Corporate News
Accession Number: 0001390478-19-000011
Submitted to the SEC: Wed Mar 06 2019 8:41:27 AM EST
Accepted by the SEC: Wed Mar 06 2019
Period: Wednesday, March 6, 2019
Industry: Pharmaceutical Preparations
Events:
  1. Financial Exhibit
  2. New Agreement
  3. Security Holders Change
  4. Unregistered Sales

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/sls/0001390478-19-000011.htm